<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02176109</url>
  </required_header>
  <id_info>
    <org_study_id>gre-lam-fer</org_study_id>
    <secondary_id>Métabolismes des LAM</secondary_id>
    <nct_id>NCT02176109</nct_id>
  </id_info>
  <brief_title>Metabolism Des LAM</brief_title>
  <acronym>LAM-ROS</acronym>
  <official_title>Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators study the prognostic role of oxidative stress metabolism and
      iron in Acute myeloid leukemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary goal of this study is to Evaluate the characteristics of regulatory networks of iron
      and redox balance in leukemic cells, to study the correlations between the prognosis of AML
      patients (in terms of response to induction chemotherapy and survival i) and metabolism of
      these markers. Secondary ones areto assess the impact of induction therapy on markers of
      oxidative stress and to correlate biological iron and redox metabolism with the molecular
      status of patients (eg Flt3/IDH/CEBPA/NPM...).

      Eligibility criteria are patients at diagnostic of de novo acute myeloid leukemia
      (promyelocytic excluded) aged from 18 to 100 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival Event-free survival Response to induction chemotherapy, overalll survival, event-free survival</measure>
    <time_frame>five years after the inclusion</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Iron</condition>
  <condition>Acute Myeloid Leukemia</condition>
  <condition>Diagnosis</condition>
  <condition>Oxydative Stress</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      leukemic cells in order to rna and proteins study medullar plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        de novo acute myeloid leukemic patient from 18 years to 99 years. promyelocytic leukemia
        excluded
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        de novo acute myeloid leukemic patient from 18 years to 99 years at diagnosis

        Exclusion Criteria:

        age under 18 years promelocytic leukemia secondary leukemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>pascal mossuz, phd</last_name>
    <email>pmossuz@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Isere</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>pascal mossuz, phd</last_name>
      <phone>0033476763220</phone>
      <email>pmossuz@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>pascal mossuz, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>June 25, 2014</last_update_submitted>
  <last_update_submitted_qc>June 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

